Diagnos Laboratorium (Indonesia) Probability of Future Stock Price Finishing Under 206.44
| DGNS Stock | IDR 210.00 6.00 2.78% |
Diagnos |
Diagnos Laboratorium Target Price Odds to finish below 206.44
The tendency of Diagnos Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 206.44 or more in 90 days |
| 210.00 | 90 days | 206.44 | about 6.69 |
Based on a normal probability distribution, the odds of Diagnos Laboratorium to drop to 206.44 or more in 90 days from now is about 6.69 (This Diagnos Laboratorium Utama probability density function shows the probability of Diagnos Stock to fall within a particular range of prices over 90 days) . Probability of Diagnos Laboratorium price to stay between 206.44 and its current price of 210.0 at the end of the 90-day period is about 1.41 .
Assuming the 90 days trading horizon Diagnos Laboratorium Utama has a beta of -1.12 suggesting Additionally Diagnos Laboratorium Utama has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Diagnos Laboratorium Price Density |
| Price |
Predictive Modules for Diagnos Laboratorium
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Diagnos Laboratorium. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Diagnos Laboratorium Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Diagnos Laboratorium is not an exception. The market had few large corrections towards the Diagnos Laboratorium's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Diagnos Laboratorium Utama, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Diagnos Laboratorium within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.36 | |
β | Beta against Dow Jones | -1.12 | |
σ | Overall volatility | 35.41 | |
Ir | Information ratio | -0.16 |
Diagnos Laboratorium Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Diagnos Laboratorium for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Diagnos Laboratorium can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Diagnos Laboratorium generated a negative expected return over the last 90 days | |
| Diagnos Laboratorium has high historical volatility and very poor performance | |
| About 80.0% of the company shares are held by company insiders |
Diagnos Laboratorium Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Diagnos Stock often depends not only on the future outlook of the current and potential Diagnos Laboratorium's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Diagnos Laboratorium's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 B | |
| Cash And Short Term Investments | 51.2 B |
Diagnos Laboratorium Technical Analysis
Diagnos Laboratorium's future price can be derived by breaking down and analyzing its technical indicators over time. Diagnos Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Diagnos Laboratorium Utama. In general, you should focus on analyzing Diagnos Stock price patterns and their correlations with different microeconomic environments and drivers.
Diagnos Laboratorium Predictive Forecast Models
Diagnos Laboratorium's time-series forecasting models is one of many Diagnos Laboratorium's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Diagnos Laboratorium's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Diagnos Laboratorium
Checking the ongoing alerts about Diagnos Laboratorium for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Diagnos Laboratorium help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Diagnos Laboratorium generated a negative expected return over the last 90 days | |
| Diagnos Laboratorium has high historical volatility and very poor performance | |
| About 80.0% of the company shares are held by company insiders |
Other Information on Investing in Diagnos Stock
Diagnos Laboratorium financial ratios help investors to determine whether Diagnos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagnos with respect to the benefits of owning Diagnos Laboratorium security.